(Q53580865)
Statements
Cost-effectiveness and quality-of-life assessment of GM-CSF as an adjunct to intensive remission induction chemotherapy in elderly patients with acute myeloid leukemia. (English)
Uyl-de Groot CA
Löwenberg B
Vellenga E
Suciu S
Willemze R
Rutten FF
1 March 1998
100
4
629-636
1 reference
1 reference
1 reference
1 reference